Publicly Traded Diagnostic Companies: CancerU.S. Exchanges
List of Publicly Traded Cancer Diagnostic Companies Listed on Major U.S. Exchanges
This group of companies provides diagnostic products that are used to aid in the detection and treatment of various forms of cancer. Additional cancer focused companies can be found in our Cancer Research and Treatment Companies section.
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Select the company’s link to access charts, news links and company website and social media information.
Cancer Diagnostic Companies: Small-Cap Stocks
EXACT Sciences Corporation (EXAS) (Molecular diagnostics)
Foundation Medicine, Inc. (FMI) (Molecular information company)
Genomic Health, Inc. (GHDX) (Molecular diagnostics)
Myriad Genetics, Inc. (MYGN) (Hereditary cancer, nephrology, autoimmune diseases, diabetes, neuropsychiatry)
Cancer Diagnostic Companies: Micro-Cap Stocks
Invitae Corporation (NVTA) (Genetic diagnostics for hereditary disorders)
Navidea Biopharmaceuticals, Inc. (NAVB) (Precision diagnostics, therapeutics and radiopharmaceutical agents)
OncoCyte Corporation (OCX) (Liquid biopsy cancer diagnostic tests)
VolitionRX Limited (VNRX) (Singapore: diagnostic tests for cancer and other diseases)
Cancer Diagnostic Companies: Nano-Cap Stocks
Biocept, Inc. (BIOC) (Molecular oncology diagnostics)
Cancer Genetics, Inc. (CGIX) (DNA-based diagnostics)
Check-Cap Ltd. (CHEK) (IPO in January 2015, Israel: Ingestible imaging capsule for the screening for colorectal cancer)
Genetic Technologies Ltd. (GENE) (Molecular diagnostics: cancer management tests)
Rosetta Genomics Ltd. (ROSG) (Israel: Molecular oncology)